Records containing: Targeted Therapy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-15Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations
-
CLINICAL_TRIALS study record update · 2026-02-27Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy: A Multicenter, Prospective, Observational Clinical Study
-
CLINICAL_TRIALS study record update · 2026-01-26An Open-label and Dose-escalation Phase I Clinical Study to Evaluate the Tolerability, Safety, and Pharmacokinetics of HLA-G-targeted Exosome (SOB100) in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2026-01-21Cohort Study of Neoadjuvant Treatment Modalities for Esophageal Cancer
-
CLINICAL_TRIALS study record update · 2026-01-21SHR-1811 Combined With Bevacizumab as Second-line Treatment in Patients Metastatic CRC
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-21Cohort Study of Definitive Chemoradiotherapy for Esophageal or Esophagogastric Junction Cancer
-
CLINICAL_TRIALS study record update · 2025-12-29A Prospective Randomized Controlled Trial Comparing Low-Dose Radiotherapy Combined With Targeted Therapy and Immunotherapy Versus Targeted Therapy and Immunotherapy Alone as Neoadjuvant Therapy in Patients With Operable Head and Neck Squamous Cell Carcinoma.
-
CLINICAL_TRIALS study record update · 2025-11-24Patient-centered, Optimal Integration of Survivorship and Palliative Care
-
CLINICAL_TRIALS study record update · 2025-11-17Efficacy and Safety of Sequential TACE-SBRT Combined With Targeted Immunotherapy in Patients With Intermediate to Advanced Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2025-09-30Short-Course Radiotherapy Combined With CAPOX and Bevacizumab, With or Without PD-1 Inhibitors, as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
-
CLINICAL_TRIALS study record update · 2025-08-24Trifluridine and Tipiracil Hydrochloride Tablets, Bevacizumab and Sintilimab With/Without Involved Lesions Irradiation as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer: a Phase 2, Double Cohort Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-06-26Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases: A Randomized, Controlled, Multicenter Phase II Trial
-
CLINICAL_TRIALS study record update · 2025-06-13A Prospective, Single-arm Clinical Study of Immune-targeted Therapy Combined With Lysogenic HSV Virus for the Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
-
CLINICAL_TRIALS study record update · 2025-05-20Efficacy Analysis of the Combined Target - Immunotherapy and XELOX Chemotherapy Regimen in the Treatment of Advanced Hepatocellular Carcinoma.
-
CLINICAL_TRIALS study record update · 2025-05-14A Multicenter, Prospective Phase II Clinical Study of High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
-
CLINICAL_TRIALS study record update · 2025-03-21Prospective Study on the Efficacy and Safety of Stereotactic Ablative Body Radiotherapy Combined with Axitinib and Toripalimab in Recurrent or Metastatic Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2024-12-19A Prospective, Single-arm Clinical Study of Immune-targeted Therapy Combined With Lysogenic HSV Virus for the Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
-
CLINICAL_TRIALS study record update · 2024-11-19Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC
-
CLINICAL_TRIALS study record update · 2024-07-31Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer
-
CLINICAL_TRIALS study record update · 2024-03-12Precision Therapy for Solid Tumors: Synergistic Inhibition of Cell Proliferation and Angiogenesis Via CDK4/6 and Anti-VEGF Approach Targeting LncRNA Expression
-
CLINICAL_TRIALS study record update · 2023-11-21Application of the RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for Advanced Non-small Cell Lung Cancer With Positive Driving Genes
-
CLINICAL_TRIALS study record update · 2023-08-09A Prospective Cohort, Open, Phase II Clinical Study of Chidamide/Everolimus Combined With Endocrine Therapy for PIK3CA Wild-type/Mutant Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative Advanced Breast Cancer
-
CLINICAL_TRIALS study record update · 2023-03-28AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies
-
CLINICAL_TRIALS study record update · 2022-04-13Efficacy and Safety of Niraparib in Combination With Anlotinib Based on CA 125 Level in Newly Diagnosed Ovarian Cancer: A Open-label, Single Arm, Prospective Phase II Trial
-
CLINICAL_TRIALS study record update · 2022-04-04Efficacy and Safety of Donafenib Combined With Paclitaxel and Platinum in Patients With Recurrent, Metastatic, and Persistent Advanced Cervical Cancer: A Single-arm, Phase II Study